Sl. No. Vaccine Name Company Type of Vaccine Stage of Development
CoronaVac
Sinovac Research and Development Co., Ltd
Inactivated virus
Phase 4
BBIBP-CorV
Sinopharm
Inactivated virus
Phase 4
ChAdOx1-S - (AZD1222)
AstraZeneca & University of Oxford
Viral vector
Phase 4
Ad26.COV2.S
Janssen Pharmaceutical
Viral vector
Phase 4
mRNA-1273
Moderna & National Institute of Allergy and Infectious Diseases (NIAID)
RNA-based
Phase 4
BNT162b2 also known as ”Comirnaty”
Pfizer/BioNTech & Fosun Pharma
RNA-based
Phase 4
MVC-COV1901
Medigen Vaccine Biologics, Dynavax & National Institute of Allergy and Infectious Diseases (NIAID)
Protein-sub unit
Phase 4
Recombinant COVID-19 vaccine for Inhalation (Ad5-nCoV-IH)
CanSino Biological Inc./Beijing Institute of Biotechnology
Viral vector
Phase 3
Gam-COVID-Vac  Adeno-based
Gamaleya Research Institute; Health Ministry of the Russian Federation
Viral vector
Phase 3
SARS-CoV-2 rS/Matrix M1-Adjuvant
Novavax
Protein- subunit
Phase 3
Recombinant SARS-CoV-2 vaccine
Anhui Zhifei Longcom Biopharmaceutical & Institute of Microbiology, Chinese Academy of Sciences
Protein- subunit
Phase 3
CVnCoV Vaccine
CureVac AG
RNA-based
Phase 3
SARS-CoV-2 vaccine
Institute of Medical Biology & Chinese Academy of Medical Sciences
Inactivated virus
Phase 3
QazCovid-in®
Research Institute for Biological Safety Problems, Rep of Kazakhstan
Inactivated virus
Phase 3
nCov vaccine
Zydus Cadila
DNA-based
Phase 3
BBV152 vaccine
Bharat Biotech International Limited
Inactivated virus
Phase 3
VAT00008
Sanofi Pasteur & GSK
Protein-sub unit
Phase 3
Inactivated SARS-CoV-2 vaccine
Shenzhen Kangtai Biological Products Co., Ltd.
Inactivated vaccine
Phase 3
CpG 1018/Alum-adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Subunit Vaccine (SCB-2019)
Clover Biopharmaceuticals Inc./Dynavax
Protein-sub unit
Phase 3
COVAX-19®
Vaxine Pty Ltd./CinnaGen Co
Protein-sub unit
Phase 3
FINLAY-FR-2 anti-SARS-CoV-2 Vaccine
Instituto Finlay de Vacunas
Protein-sub unit
Phase 3
EpiVacCorona
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology ”Vector”
Protein-sub unit
Phase 3
ARCoV
Academy of Military Science (AMS), Walvax Biotechnology, and Suzhou Abogen Biosciences
RNA-based
Phase 3
Coronavirus-Like Particle COVID-19 (CoVLP)
Medicago Inc.
Virus like particle
Phase 3
COVI-VAC
Codagenix/Serum Institute of India
Live attenuated
Phase 3
CIGB-66
The Center for Genetic Engineering and Biotechnology (CIGB)
Protein-sub unit
Phase 3
VLA2001
Valneva, National Institute for Health Research, United Kingdom
Inactivated vaccine
Phase 3
BECOV2
Biological E. Limited
Protein-sub unit
Phase 3
Nanocovax
Nanogen Pharmaceutical Biotechnology
Protein-sub unit
Phase 3
TURKOVAC
Erciyes University and the Health Institutes of Turkey (TUSEB)
Inactivated virus
Phase 3
GBP510
SK Bioscience Co., Ltd., and CEPI
Protein-sub unit
Phase 3
Razi Cov Pars
Razi Vaccine and Serum Research Institute
Protein-sub unit
Phase 3
Noora vaccine
Bagheiat-Allah University of Medical Sciences/AmitisGen
Protein-sub unit
Phase 3
Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
Livzon Pharmaceutical
Protein-sub unit
Phase 3
ARCT-154
Arcturus Therapeutics, Inc.
RNA-based
Phase 3